A novel thienylhydrazone, (2-thienylidene)3,4-methylenedioxybenzoylhydrazine, increases inotropism and decreases fatigue of skeletal muscle

Journal of Pharmacology and Experimental Therapeutics

Volumn 299, Issue 2, 2001, Pages 558-566

  Gonzalez Serratos, Hugo ^a   Chang, Ruzhang ^a   Pereira, Edna F R ^a   Castro, Newton G ^b   Aracava, Yasco ^b   Melo, Paulo A ^b   Lima, Patrícia C ^b   Fraga, Carlos A M ^b   Barreiro, Eliezer J ^b   Albuquerque, Edson X ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

(2 THIENYLIDENE) 3,4 METHYLENEDIOXYBENZOYLHYDRAZINE; ANTIINFLAMMATORY AGENT; CALCIUM ION; CYCLIC AMP; DIMETHYL SULFOXIDE; HYDRAZONE DERIVATIVE; LASSBIO 294; PHOSPHODIESTERASE INHIBITOR; PYRIDAZINONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; FROG; INOTROPISM; MUSCLE FATIGUE; MUSCLE TONE; MUSCLE TWITCH; NONHUMAN; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM; SEMITENDINOUS MUSCLE; SKELETAL MUSCLE; TIBIALIS ANTERIOR MUSCLE;

ACTION POTENTIALS; ANIMALS; CARDIOTONIC AGENTS; ELECTRIC STIMULATION; HYDRAZONES; MEMBRANE POTENTIALS; MUSCLE CONTRACTION; MUSCLE FATIGUE; MUSCLE FIBERS; MUSCLE, SKELETAL; MYOCARDIAL CONTRACTION; RANA PIPIENS; THIOPHENES;

EID: 0034767939     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. A potent and selective inhibitor of cyclic AMP phosphodiesterase with potential cardiotonic and antithrombotic properties
2. Regulatory mechanisms involved in the control of cyclic adenosine 3′:5′-monophosphate phosphodiesterases in myoblasts
3. Sodium dependence of the inward spread of activation in isolated twitch muscle fibres of the frog
4. Alterations in heart failure of cyclic AMP-dependent inotropic and lusitropic properties of cardiac and skeletal muscle
5. Exercise capacity and quality of life in the treatment of heart failure
6. Direct measurement of skeletal muscle fatigue in patients with chronic heart failure
7. i during beta-adrenoceptor activation of single, intact fibres from mouse skeletal muscle
8. Clenbuterol reduces soleus muscle fatigue during disuse in aged rats
9. 2+] in the development of low frequency fatigue in mouse single muscle fibres
10. The contribution of pH-dependent mechanisms to fatigue at different intensities in mammalian single muscle fibres
11. The Na+, K+ pump in skeletal muscle: Quantification, regulation and functional significance
12. Calcium efflux from frog twitch muscle fibers
13. A new procedure for the isolation of plasma membranes T tubules, and internal membranes from skeletal muscle
14. Myofibrillar fatigue versus failure of activation during repetitive stimulation of frog muscle fibres
15. Design and synthesis of novel potent antinociceptive agents: N-acetyl-imidazolyl N-acylhydrazone derivatives
16. Cyclic nucleotide phosphodiesterases: Relating structure and function
17. The effects of milrinone and its mechanism in the fatigued diaphragm in dogs
18. Differential activation of myofibrils during fatigue in phasic skeletal muscle cells
19. Changes of intracellular milieu with fatigue or hypoxia depress contraction of skinned rabbit skeletal and cardiac muscle
20. Effects of catecholamines and cyclic amp on excitation-contraction coupling in isolated skeletal muscle fibres of the frog
21. Composition of vacuoles and sarcoplasmic reticulum in fatigued muscle: Electron probe analysis
22. Slow inward calcium currents have no obvious role in muscle excitation-contraction coupling
23. Deficient cellular cyclic AMP may cause both cardiac and skeletal muscle dysfunction in heart failure
24. Exercise limitation in health and disease
25. The effect of beta 2-adrenoceptor activation on ion-shifts and fatigue in mouse soleus muscles stimulated in vitro
26. Adenosine 3′:5′-monophosphate-dependent protein kinase-catalyzed phosphorylation reaction and its relationship to calcium transport in cardiac sarcoplasmic reticulum
27. Theophylline, fatigue, and diaphragm contractility: Cellular levels of 45Ca and cAMP
28. Milrinone for long-term therapy of severe heart failure: Clinical experience with special reference to maximal exercise tolerance
29. Synthesis and analgesic activity of novel N-acylarylhydrazones and isosters, derived from natural safrole
30. Molecular cloning and chromosomal assignment of the human homologue of the rat cGMP-inhibited phosphodiesterase 1 (PDE3A) - A gene involved in fat metabolism located at 11p 15.1
31. Skeletal muscle fatigue in normal subjects and heart failure patients. Is there a common mechanism?
32. Effects of amrinone on the contractile behavior of striated muscle fibers
33. Abnormal intracelluIar modulation of calcium as a major cause of cardiac contractile dysfunction
34. Effects of amrinone on the electromechanical coupling in frog skeletal muscle fibres
35. 2+ transients in isolated bundles of skeletal muscle fibers from rats with chronic heart failure
36. New heterocyclic fused pyridazinones as potent and selective phosphodiesterase IV inhibitors
37. Reduced Ca(2+)-sensitivity of SERCA 2a in failing human myocardium due to reduced serin-16 phospholamban phosphorylation
38. Electron probe analysis of the sarcoplasmic reticulum and vacuolated T-tubule system of fatigued frog muscles
39. Novo protótipo cardioativo com atividade inotrópica positiva: LASSBio-294
40. Salbutamol enhances isotonic contractile properties of rat diaphragm muscle
41. Exercise intolerance in heart failure. Importance of skeletal muscle
42. Myofibrillar bound cyclic nucleotide phosphodiesterase in heart and skeletal muscle